ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.145
+0.005 (0.44%)
Apr 17, 2025, 4:00 PM EDT - Market closed
ProQR Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$8.50
Upside
+642.36%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Chardan Capital | Chardan Capital | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +249.34% | Mar 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +948.03% | Mar 14, 2025 |
Jones Trading | Jones Trading | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +860.70% | Feb 12, 2025 |
JMP Securities | JMP Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +598.69% | Dec 12, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +249.34% | Dec 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +773.36% | Dec 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +773.36% | Nov 8, 2024 |
Raymond James | Raymond James | Buy → Strong Buy Upgrades $6 → $14 | Buy → Strong Buy | Upgrades | $6 → $14 | +1,122.71% | Oct 29, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +336.68% | May 10, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $2.5 | Strong Buy | Maintains | $2.5 | +118.34% | May 10, 2024 |
Citigroup | Citigroup | Hold Maintains $1.8 → $2 | Hold | Maintains | $1.8 → $2 | +74.67% | Apr 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +336.68% | Mar 14, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $2 → $2.5 | Strong Buy | Maintains | $2 → $2.5 | +118.34% | Mar 14, 2024 |
Raymond James | Raymond James | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +249.34% | Nov 8, 2023 |
Chardan Capital | Chardan Capital | Hold → Strong Buy Upgrades $2 | Hold → Strong Buy | Upgrades | $2 | +74.67% | Nov 8, 2023 |
Citigroup | Citigroup | Hold Maintains $2.1 → $1.8 | Hold | Maintains | $2.1 → $1.8 | +57.21% | Sep 18, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.